nebivolol   Click here for help

GtoPdb Ligand ID: 7246

Synonyms: Bystolic® | R-65824 | Ro-67555
Approved drug
nebivolol is an approved drug (FDA (2007))
Compound class: Synthetic organic
Comment: Nebivolol is a β-blocker, selective for β1-adrenoceptors.
Marketed formulations may contain nebivolol hydrochloride (PubChem CID ).
Click here for help
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: nebivolol

2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 3
Rotatable bonds 6
Topological polar surface area 70.95
Molecular weight 405.18
XLogP 2.74
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O
Isomeric SMILES OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O
InChI InChI=1S/C22H25F2NO4/c23-15-3-7-19-13(9-15)1-5-21(28-19)17(26)11-25-12-18(27)22-6-2-14-10-16(24)4-8-20(14)29-22/h3-4,7-10,17-18,21-22,25-27H,1-2,5-6,11-12H2
No information available.
Summary of Clinical Use Click here for help
Used to treat hypertension and left ventricular failure.
Byvalson® a fixed-dose combination drug containing nebivolol (5mg) and valsartan (80mg; an angiotensin AT1 receptor antagonist) was approved by the FDA in June 2016 for the treatment of hypertension.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Antagonism of β-adrenoceptors prevents the receptors from processing signals from endogenous epinephrine and norepinephrine, resulting in decreased force of heart contractions and lowered heart rate.
External links Click here for help